Aubrey Winn, MD
Dermatology · Granite Bay
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Orisek and Mccaskill Medical Group, Inc. · 3 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Winn’s office at (916) 771-0715 to ask if they take your plan before you enroll.
State licence records
1 licence
- Washington MD.MD.61422430Physician And Surgeon License · since 2023 · expires 2025-09-22ExpiredNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Original Medicare doctor bills
$277,323
Medicare paid this office $277,323 for 234 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | 11 | $6,722 | $480 |
| Short return visit (20+ min) | 85 | $6,351 | $68 |
| Destruction of skin growth, 1-14 growths | 45 | $4,625 | $91 |
| Destruction of precancer skin growth, 1 growth | 98 | $4,520 | $41 |
| Return visit (30+ min) | 32 | $3,475 | $102 |
See all 12 services
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | 11 | $6,722 | $480 |
| Short return visit (20+ min) | 85 | $6,351 | $68 |
| Destruction of skin growth, 1-14 growths | 45 | $4,625 | $91 |
| Destruction of precancer skin growth, 1 growth | 98 | $4,520 | $41 |
| Return visit (30+ min) | 32 | $3,475 | $102 |
| Biopsy of related skin growth, first growth | 47 | $3,431 | $71 |
| New patient visit (45+ min) | 27 | $3,039 | $113 |
| New patient visit (30+ min) | 35 | $2,798 | $80 |
| Destruction of precancer skin growth, 2-14 growths | 73 | $2,150 | $6 |
| Short return visit | 41 | $1,883 | $43 |
| New patient visit (15+ min) | 17 | $1,047 | $62 |
| Biopsy of related skin growth, each additional growth | 14 | $882 | $40 |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 1-10 | None |
| Removal of skin cancer | 27 | More than 12% of doctors who do this |
| Removal of skin lesions | 96 | More than 75% of doctors who do this |
| Removal of tissue | 1-10 | None |
| Removal or shaving of skin growth | 1-10 | None |
| Skin biopsy | 25 | More than 65% of doctors who do this |
Who their Medicare patients are
234 Original Medicare patients in 2024. Average age 76 · Under 65 5% · 85 and older 14% · Women 54% · Also on Medicaid 14% · Health risk score 1.07. Above the middle of the specialty; the typical dermatology clinician is at 1.01.
Conditions among them: High blood pressure 61% · Coronary heart disease 24% · Diabetes 20% · Chronic kidney disease 18% · Atrial fibrillation 18% · Cancer 17% · Depression 13% · Heart failure 9% · COPD 9% · Dementia 6% · Stroke 5%.
The office billed $442,570, Medicare allowed $352,485 and paid $277,323; for 1,160 services of 57 kinds; $220,648 of it was for drugs given in the office and $56,675 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 234 | 1,160 | 76 | 1.07 | $442,570 | $277,323 |
| 2023 | 88 | 592 | 77 | 1.23 | $368,379 | $259,771 |
| 2022 | 61 | 343 | 74 | 1.07 | $48,610 | $7,164 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Membrane graft or membrane wrap, per square centimeter | 12 | $169,865 | $1,163 |
| Application of skin substitute graft to wound of face, scalp, eyelids, mouth, neck, ears, around eyes, genitals, hands, feet, fingers, or toes, 25.0 sq cm or less of wound 100.0 sq cm or less | 21 | $2,982 | $119 |
| Return visit (30+ min) | 14 | $1,899 | $100 |
| Short return visit (20+ min) | 18 | $1,361 | $68 |
| New patient visit (30+ min) | 17 | $1,330 | $78 |
| Short return visit | 26 | $1,259 | $43 |
| Destruction of precancer skin growth, 1 growth | 20 | $865 | $41 |
| Biopsy of related skin growth, first growth | 11 | $696 | $63 |
| Destruction of precancer skin growth, 2-14 growths | 16 | $435 | $5 |
2022: 6 services
| Destruction of precancer skin growth, 1 growth | 40 | $1,214 | $28 |
| New patient visit (45+ min) | 15 | $1,131 | $75 |
| Return visit (30+ min) | 12 | $1,066 | $76 |
| New patient visit (30+ min) | 23 | $977 | $42 |
| Destruction of skin growth, 1-14 growths | 15 | $734 | $46 |
| Destruction of precancer skin growth, 2-14 growths | 38 | $218 | $1 |
Drugs they prescribed that Part D paid
$6,533
Pharmacies billed $6,533 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 168) in 2024. At or below the middle of the specialty; the typical dermatology clinician is at 0%.
162 generic and fewer than 11 brand-name prescriptions · $6,533 in drug cost · 15 antibiotic prescriptions to 13 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Fluorouracil | 20 | $1,487 | $74 |
| Ketoconazole | 20 | $969 | $30 |
| Doxycycline Hyclate | 11 | $323 | $20 |
| Mupirocin | 18 | $161 | $8 |
Year by year
| 2024 | 168 | 89 | 0% (0) | None | $6,533 |
| 2023 | 84 | 48 | None | 18% | $159,065 |
| 2022 | 168 | 79 | 0% (0) | 18% | $226,722 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Ketoconazole | 15 | $385 | $26 |
| Mupirocin | 11 | $104 | $9 |
2022: 2 drugs
| Ketoconazole | 30 | $915 | $31 |
| Imiquimod | 18 | $528 | $29 |
Money from drug and device companies
$566 in 2025
| 2025 | 10 | 16 | None | $566 |
| 2024 | 4 | 5 | None | $116 |
| 2023 | 2 | 2 | None | $44 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| E.R. Squibb & Sons L.L.C. | Sotyktu | $122 | 1 payment
|
| Revance Therapeutics | Daxxify | $106 | 4 payments
|
| Pfizer | Litfulo | $95 | 1 payment
|
| Regeneron Healthcare Solutions | Dupixent | $62 | 2 payments
|
| Ucb | Bimzelx | $61 | 3 payments
|
| Merz North America | Xeomin | $28 | 1 payment
|
See all 16 published payments
| Revance Therapeutics | Meals · 2025-12-15 | Daxxify | $37 |
| Revance Therapeutics | Meals · 2025-12-15 | Daxxify | $14 |
| Revance Therapeutics | Meals · 2025-12-08 | Daxxify | $25 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-11-17 | Jublia | $21 |
| Revance Therapeutics | Meals · 2025-11-04 | Daxxify | $30 |
| Ucb | Meals · 2025-10-22 | Bimzelx | $20 |
| Merz North America | Meals · 2025-09-05 | Xeomin | $28 |
| Ucb | Meals · 2025-08-06 | Bimzelx | $26 |
| Regeneron Healthcare Solutions | Meals · 2025-06-13 | Dupixent | $25 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-05-13 | Sotyktu | $122 |
| Janssen Biotech | Meals · 2025-04-09 | Tremfya | $18 |
| Abbvie | Meals · 2025-04-02 | Skyrizi | $26 |
| Ucb | Meals · 2025-03-18 | Bimzelx | $15 |
| Sun Pharmaceutical Industries | Meals · 2025-03-12 | Winlevi | $25 |
| Pfizer | Meals · 2025-03-05 | Litfulo | $95 |
| Regeneron Healthcare Solutions | Meals · 2025-01-10 | Dupixent | $37 |
See earlier years (2024, 2023)
2024: $116
| Organogenesis | None | $39 | 1 payment
|
| Novartis Pharmaceuticals | Cosentyx | $33 | 2 payments
|
| Lilly USA | Taltz | $22 | 1 payment
|
| Ucb | Bimzelx | $21 | 1 payment
|
2023: $44
| Smith+Nephew | Grafix | $26 | 1 payment
|
| Dermavant Sciences | Vtama | $17 | 1 payment
|
Professional record
- NPI
- 1861803330
- Licence
- WA MD61422430Washington MD.MD.61422430: Expired
- Trained
- Loma Linda University School of Medicine, 2014
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207N00000X (207N00000X); Federal specialty code 207ND0101X (207ND0101X); Federal specialty code 207NS0135X (207NS0135X)
- Mailing address
- 2450 Ne Mary Rose Pl Ste 201, Bend, OR, 97701
- NPI first listed
- 2014-05-18
- NPI last updated
- 2026-09-02
- NPI record certified
- 2026-09-02
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: Walter Reed Nmmc Graduate Medical, Bethesda, MD, 20889 · 9460 N Name Uno Ste 210, Gilroy, CA, 95020 · 114 E Romie Ln, Salinas, CA, 93901 · 3311 Mission Dr, Santa Cruz, CA, 95065 · 510 S Cowley St, Spokane, WA, 99202